Kestra Medical Technologies, Ltd. Common Stock KMTS Cash Flow Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| -$143.89M-66.9% | -$131.48M-49.4% | -$119.32M-31.2% | -$113.81M-20.9% | -$86.23M— | ||
| $8.22M-8.9% | $8.13M-18.9% | $7.62M-31.0% | $7.97M-31.1% | $9.02M— | ||
| $45.65M+1,859% | $36M+1,505% | $28.47M+1,807% | $24.27M+1,531% | $2.33M— | ||
| —— | —— | —— | $64K+433% | $51K— | ||
| $1.78M+50.0% | $1.48M+26.6% | $1.67M+154% | $1.4M+130% | $1.18M— | ||
| -$1.94M-68.7% | -$2.07M-86.0% | -$2.12M-100% | -$2.09M-95.7% | -$1.15M— | ||
| $7.11M-15.8% | $7.79M+36.2% | $7.66M+60.9% | $8.78M+251% | $8.44M— | ||
| —— | —— | —— | —— | $5.5M— | ||
| $6.08M+115% | $3.35M+70.0% | $3.62M+765% | $4.62M+1,144% | $2.82M— | ||
| -$40K-45.5% | -$40K-167% | -$40K-1,500% | -$40K-500% | -$27.5K— | ||
| —— | —— | —— | —— | —— | ||
| -$399K-460% | -$67K+39.4% | $210K+164% | $370K+179% | $110.75K— | ||
| -$87.04M-21.5% | -$86.67M-20.9% | -$86.38M-20.5% | -$77.61M-7.4% | -$71.61M— | ||
| $32.62M+75.3% | $26.88M+52.8% | $24.07M+48.5% | $22.94M+87.6% | $18.6M— | ||
| -$37.98M-100% | -$27.51M-56.6% | -$24.51M-51.2% | -$23.31M-90.6% | -$18.96M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $215.79M— | —— | ||
| —— | —— | —— | —— | —— | ||
| $361.98M— | —— | —— | —— | —— | ||
| $236.97M— | —— | —— | —— | —— | ||
| —— | $5.25M+23.0% | $5.05M+28.2% | $4.85M+33.6% | $4.54M— | ||
| —— | —— | —— | —— | —— | ||
| $1.78M+50.0% | $1.48M+26.6% | $1.67M+154% | $1.4M+130% | $1.18M— | ||
| $6.08M+115% | $3.35M+70.0% | $3.62M+765% | $4.62M+1,144% | $2.82M— | ||
| —— | -$2.92M-71.3% | -$3.3M-123% | -$3.44M-193% | -$3.12M— | ||
| -$399K-460% | -$67K+39.4% | $210K+164% | $370K+179% | $110.75K— | ||
| —— | $846K— | —— | —— | —— | ||
| $359K-29.9% | $322K-46.9% | $325K-53.5% | $416K-42.9% | $512.25K— | ||
| —— | —— | —— | $855K-22.1% | $977.5K— | ||
| $2.33M+15.8% | $2.77M+109% | $2.6M+141% | $2.69M+439% | $2.01M— | ||
| —— | —— | —— | —— | —— | ||
| $555K-20.6% | $796K+133% | $738K+213% | $655K+127% | $699K— | ||
| $197K-42.3% | $173K-53.2% | $297K+25.4% | $283K-0.7% | $341.25K— | ||
| —— | —— | —— | $1.65M+107% | $1.85M— | ||
| —— | —— | —— | $3.52M— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $2.37M— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $1.88M— | —— | ||
| —— | —— | —— | $280.51M— | —— | ||
| —— | —— | -$923K— | $2.65M— | —— | ||
| -$399K-460% | -$67K+39.4% | $210K+164% | $370K+179% | $110.75K— | ||
| —— | —— | —— | $5.45M— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$119.66M-32.6% | -$113.55M-27.2% | -$110.45M-25.7% | -$100.54M-19.0% | -$90.21M— | ||
| -$119.66M-32.6% | -$113.55M-27.2% | -$110.45M-25.7% | -$100.54M-19.0% | -$90.21M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Kestra Medical Technologies, Ltd. Common Stock generate?
- Kestra Medical Technologies, Ltd. Common Stock (KMTS) generated -$87.0M in operating cash flow over the trailing twelve months.
- What is Kestra Medical Technologies, Ltd. Common Stock's free cash flow?
- After $32.6M of capital expenditures, Kestra Medical Technologies, Ltd. Common Stock's free cash flow was -$119.7M over the trailing twelve months, down 32.6% year over year.
- Where does Kestra Medical Technologies, Ltd. Common Stock's cash flow data come from?
- Every line is extracted from Kestra Medical Technologies, Ltd. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
